Physician profile
Emmanuel E Harrison
NPI 1912957762
$943.11
in general payments reported to CMS, 2019-2025
16 companies · $363 in 2025
The $363 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.57 · 2023: $106 · 2024: $410 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $228.89 | 2023-2025 | Ajovy |
| Merz Pharmaceuticals, LLC | $152.93 | 2024-2025 | Xeomin |
| Jazz Pharmaceuticals INC. | $100.49 | 2023-2024 | |
| Ucb, INC. | $65.66 | 2025 | Rystiggo |
| Takeda Pharmaceuticals U.S.A., INC. | $61.35 | 2022-2023 | Gammagard |
| Scilex Pharmaceuticals INC. | $51.13 | 2024-2025 | |
| Lundbeck LLC | $46.48 | 2024 | Vyepti |
| Sk Life Science, INC. | $42.03 | 2025 | |
| Argenx US, INC. | $37.97 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Azurity Pharmaceuticals, INC. | $34.88 | 2024 | Horizant |
| Csl Behring | $32.71 | 2022-2023 | Hizentra |
| Axsome Therapeutics, INC. | $23.67 | 2025 | Sunosi |
| Tonix Medicines, INC. | $17.93 | 2025 | Zembrace Symtouch |
| Phadia US INC. | $17.09 | 2024 | Immunocap |
| Emd Serono, INC. | $15.44 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $14.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.